Merck To Pay $23M To Settle Vioxx Economic-Loss Claims
Merck & Co. Inc. has agreed to pay up to $23 million to settle putative class claims of consumers who allege they suffered economic loss due to the drugmaker's purported misrepresentations...To view the full article, register now.
Already a subscriber? Click here to view full article